Safety and efficacy of celecoxib, a specific COX-2 inhibitor, in patients with rheumatoid arthritis.

被引：0
|
作者：
Geis, GS [1 ]
Hubbard, R [1 ]
Callison, D [1 ]
Yu, S [1 ]
Zhao, W [1 ]
机构：
[1] GD Searle & Co, Skokie, IL 60077 USA
来源：
ARTHRITIS AND RHEUMATISM | 1998年 / 41卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1990
引用
收藏
页码：S364 / S364
页数：1
相关论文
共 50 条
  • [41] Isolation, synthesis and characterization of impurities in Celecoxib a cox-2 inhibitor
    Satyanarayana, U
    Rao, DS
    Kumar, YR
    Babu, JM
    Kumar, PR
    Reddy, JT
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2004, 35 (04) : 951 - 957
  • [42] COX-2 Inhibitor, Celecoxib, May Prevent Lung Cancer
    不详
    ONCOLOGY-NEW YORK, 2011, 25 (09): : 848 - 849
  • [43] Safety of a specific COX-2 inhibitor in aspirin-induced asthma
    Szczeklik, A
    Nizankowska, E
    Bochenek, G
    Nagraba, K
    Mejza, F
    Swierczynska, M
    CLINICAL AND EXPERIMENTAL ALLERGY, 2001, 31 (02): : 219 - 225
  • [44] Combination of COX-2 inhibitor and metformin attenuates rate of admission in patients with rheumatoid arthritis and diabetes in Taiwan
    Lu, Chieh-Hua
    Chung, Chi-Hsiang
    Lee, Chien-Hsing
    Su, Sheng-Chiang
    Liu, Jhih-Syuan
    Lin, Fu-Huang
    Tsao, Chang-Huei
    Hsieh, Po-Shiuan
    Hung, Yi-Jen
    Hsieh, Chang-Hsun
    Chien, Wu-Chien
    MEDICINE, 2019, 98 (41)
  • [45] Safety and efficacy of Rituximab in the treatment of refractory rheumatoid arthritis.
    Higashida, J
    Schmidt, S
    Naguwa, S
    Wun, T
    Tuscano, JM
    BLOOD, 2003, 102 (11) : 288A - 288A
  • [46] Celecoxib, a COX-2 specific inhibitor, is associated with a lower incidence of serious upper gastrointestinal (UGI) events in arthritis patients than comparator NSAIDs.
    Goldstein, JL
    Agrawal, NM
    Silverstein, F
    Hubbard, RC
    Zhao, W
    Geis, GS
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S280 - S280
  • [47] Efficacy and gastrointestinal safety profiles of celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, in the rat
    Kobayashi, S
    Yoshino, T
    Kimoto, A
    Hayashi, A
    Tanaka, H
    Miyata, K
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 118P - 118P
  • [48] Upper gastrointestinal (UGI) tolerability of valdecoxib, a COX-2 specific inhibitor, compared with nonspecific NSAIDs among patients with osteoarthritis and rheumatoid arthritis
    Goldstein, JL
    Eisen, G
    Hanna, DB
    Burke, T
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 278 - 279
  • [49] Valdecoxib, a novel COX-2 specific inhibitor, is safe and well tolerated in elderly osteoarthritis (OA) and rheumatoid arthritis (RA) patients.
    Recker, DP
    Kent, JD
    Hounslow, N
    Lau, W
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (04) : S144 - S145
  • [50] Are selective COX-2 inhibitors as effective as NSAIDs in patients with rheumatoid arthritis?
    Smucny, J
    AMERICAN FAMILY PHYSICIAN, 2004, 69 (03) : 595 - 596
12345